News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Clarus Lifesciences III, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/01/2022 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 7.2% stake in Imago BioSciences, Inc. |
| 01/12/2022 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 5% stake in ESSA PHARMA INC. |
| 07/30/2021 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 10.5% stake in Imago BioSciences, Inc. |
| 07/09/2020 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 4.9% stake in Entasis Therapeutics Holdings Inc. |
| 05/01/2020 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 11.1% stake in Entasis Therapeutics Holdings Inc. |
| 09/06/2019 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 16.7% stake in ESSA PHARMA INC. |
| 08/05/2019 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 0% stake in AVROBIO, Inc. |
| 10/12/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 8.9% stake in Gritstone Oncology, Inc. |
| 10/09/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 12.4% stake in Entasis Therapeutics Holdings Inc. |
| 07/12/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/05/2018 |
SC 13D
| Clarus Lifesciences III, L.P. reports a 12.8% stake in Avrobio, Inc. |
| 06/19/2018 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 30.2% stake in ESSA PHARMA INC. |
| 02/09/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/13/2015 |
SC 13G
| Clarus Lifesciences III, L.P. reports a 7.9% stake in Neothetics, Inc. |
|
|